Janssen R&D US
Why I'm a JPAL
As a former consultant, investment analyst and academic, I have had a long-term passion for helping advise startup companies on helping to translate their early stage technologies and assets into products. Specifically, I have advised companies on matters spanning science/technology, IP strategy, and business strategy and execution.
My background spans science, IP and business, with experience in academic research as a faculty member, a biotech hedge fund analyst, a consultant and entrepreneur, and the pharmaceutical industry. Prior to joining Janssen in 2015, I was Founder and President of Biomedical Intelligence, a consulting company focused on business development, market and competitive analysis, and strategy for clients. I ran a successful business for 7 years, at which point I was recruited by Janssen Pharmaceuticals to help drive strategic analysis, external innovation and partnering to help build a differentiated, competitive pipeline of biologics. In March 2019, my role was expanded to encompass all modalities (small molecules, antibodies, nucleic acids, gene and cell therapies), from discovery through product development and clinical supply. In each of these roles, I have worked closely with leaders and scientists from all major therapeutic areas. I thrive working in highly matrixed, cross-functional teams, and I have forged a wide network across the industry.
"It is amazing what you can accomplish if you do not care who gets the credit."
- Harry S Truman
I am fluent in Polish.